Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jacques Morel

Showing results (111-120 of 197) with videos related to

Pageof 20
Sort By:
ACR Open Rheumatology|May 9, 2025
Analysis of the Impact of Tofacitinib Treatment on Weight and Body Mass Index in Patients With Rheumatoid ArthritisJürgen Wollenhaupt, Jacques Morel, Claire Daien, et al.
Immunologic Research|August 27, 2016
Mastitis associated with Sjögren's syndrome: a series of nine casesRadjiv Goulabchand, Assia Hafidi, Ingrid Millet, et al.
Annals of Medicine|September 29, 2022
Hospitalizations for infections in primary Sjögren's syndrome patients: a nationwide incidence studyRadjiv Goulabchand, Alain Makinson, Jacques Morel, et al.
Autoimmunity Reviews|October 31, 2021
Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization databaseRadjiv Goulabchand, Nicolas Malafaye, William Jacot, et al.
Joint Bone Spine|June 28, 2005
Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Société Française de Rhumatologie, SFR)Thao Pham, Pascal Claudepierre, Xavier Deprez, et al.
Annals of the Rheumatic Diseases|November 27, 2012
The TNF family member APRIL dampens collagen-induced arthritisLeticia Fernandez, Gabriela Franco Salinas, Cecilia Rocha, et al.
Rheumatology (Oxford, England)|October 26, 2017
Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry dataJean-Hugues Salmon, Jeanne-Marie Perotin, Jacques Morel, et al.
Joint Bone Spine|December 17, 2008
Rituximab (MabThera) therapy and safety management. Clinical tool guideThao Pham, Bruno Fautrel, Jacques-Eric Gottenberg, et al.
Rheumatology (Oxford, England)|March 31, 2021
Cut-off value to identify a flare using the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire: analysis of the TOSCA studyKrystel Aouad, Philippe Gaudin, Olivier Vittecoq, et al.
Rheumatology (Oxford, England)|May 9, 2009
Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 casesClaire Immediato Daïen, Agnes Monnier, Pascal Claudepierre, et al.
Pageof 20

Showing results (111-120 of 197) with videos related to

Sort By:
Pageof 20
ACR Open Rheumatology|May 9, 2025
Analysis of the Impact of Tofacitinib Treatment on Weight and Body Mass Index in Patients With Rheumatoid ArthritisJürgen Wollenhaupt, Jacques Morel, Claire Daien, et al.
Immunologic Research|August 27, 2016
Mastitis associated with Sjögren's syndrome: a series of nine casesRadjiv Goulabchand, Assia Hafidi, Ingrid Millet, et al.
Annals of Medicine|September 29, 2022
Hospitalizations for infections in primary Sjögren's syndrome patients: a nationwide incidence studyRadjiv Goulabchand, Alain Makinson, Jacques Morel, et al.
Autoimmunity Reviews|October 31, 2021
Cancer incidence in primary Sjögren's syndrome: Data from the French hospitalization databaseRadjiv Goulabchand, Nicolas Malafaye, William Jacot, et al.
Joint Bone Spine|June 28, 2005
Anti-TNF alpha therapy and safety monitoring. Clinical tool guide elaborated by the Club Rhumatismes et Inflammations (CRI), section of the French Society of Rheumatology (Société Française de Rhumatologie, SFR)Thao Pham, Pascal Claudepierre, Xavier Deprez, et al.
Annals of the Rheumatic Diseases|November 27, 2012
The TNF family member APRIL dampens collagen-induced arthritisLeticia Fernandez, Gabriela Franco Salinas, Cecilia Rocha, et al.
Rheumatology (Oxford, England)|October 26, 2017
Serious infusion-related reaction after rituximab, abatacept and tocilizumab in rheumatoid arthritis: prospective registry dataJean-Hugues Salmon, Jeanne-Marie Perotin, Jacques Morel, et al.
Joint Bone Spine|December 17, 2008
Rituximab (MabThera) therapy and safety management. Clinical tool guideThao Pham, Bruno Fautrel, Jacques-Eric Gottenberg, et al.
Rheumatology (Oxford, England)|March 31, 2021
Cut-off value to identify a flare using the Flare Assessment in Rheumatoid Arthritis (FLARE-RA) questionnaire: analysis of the TOSCA studyKrystel Aouad, Philippe Gaudin, Olivier Vittecoq, et al.
Rheumatology (Oxford, England)|May 9, 2009
Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 casesClaire Immediato Daïen, Agnes Monnier, Pascal Claudepierre, et al.
Pageof 20